Literature DB >> 16394792

Hepatitis C treatment in drug users: perception versus evidence.

Diana Sylvestre1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16394792     DOI： 10.1097/00042737-200602000-00003

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN： 0954-691X            Impact factor:   2.566


× No keyword cloud information.
  5 in total

1.  The role of hepatology nurse in the difficult-to-treat hepatitis C population.

Authors:  Jo-Ann Ford; Cindy Cheong-Lee
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

Review 2.  Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Authors:  Lucy Platt; Silvia Minozzi; Jennifer Reed; Peter Vickerman; Holly Hagan; Clare French; Ashly Jordan; Louisa Degenhardt; Vivian Hope; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Julie Bruneau; Matthew Hickman
Journal:  Cochrane Database Syst Rev       Date:  2017-09-18

Review 3.  Tangible resources for preparing patients for antiviral therapy for chronic hepatitis C.

Authors:  Jason E Bonner; A Sidney Barritt; Michael W Fried; Donna M Evon
Journal:  Dig Dis Sci       Date:  2012-04-10       Impact factor: 3.199

4.  Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks.

Authors:  Geert Robaeys; Jozef De Bie; Marieke C Wichers; Liesbeth Bruckers; Frederik Nevens; Peter Michielsen; Marc Van Ranst; Frank Buntinx
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

5.  Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.

Authors:  Issifou Yaya; Perrine Roux; Fabienne Marcellin; Linda Wittkop; Laure Esterle; Bruno Spire; Stéphanie Dominguez; Boni Armand Elegbe; Lionel Piroth; Philippe Sogni; Dominique Salmon-Ceron; Maria Patrizia Carrieri
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.